Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1998-11-5
|
pubmed:abstractText |
Cord blood banks have increased the use of cord blood transplants (CBT) for patients with hematological disorders. EUROCORD has established a registry for providing information on the outcome of CBT. Questionnaires were sent to all EUROCORD members to collect information on patients transplanted from 1988 to 1996. One hundred and forty-three CBT, performed in 45 centers, were analyzed for survival, engraftment and graft-versus-host disease (GVHD). Results in recipients of related and unrelated transplants were analyzed separately. In 78 patients who received CB from a related donor, 1-year survival was 63 +/- 6%. Age, weight, HLA identity and negative cytomegalovirus (CMV) serology in the recipient were significant favorable prognostic factors. Among these 78 patients, the incidence of grade > or = II GVHD was 9% in HLA matched CBT and 50% in mismatched CBT. Neutrophil engraftment was associated with age < 6 years (P = 0.02), weight < 20 kg (P = 0.02). It was 73% in patients receiving < 3.7 x 10(7) nucleated cells (NC) infused/kg and 85% in patients receiving more (P = 0.06). Among 65 patients, who received CB from an unrelated donor, 1-year survival was 29 +/- 7%. Negative recipient CMV serology was associated with improved survival (P = 0.01). Acute GVHD > or = II was observed in 40% of these patients. Negative recipient CMV serology was the most important factor for predicting GVHD (P = 0.04). Neutrophil recovery was 76% in patients receiving < 3.7 x 10(7) NC/kg and 94% in patients receiving more (P = 0.008). Cord blood is a feasible alternative source of hematopoietic stem cells for treating patients with various hematological disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S68-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9715895-Adolescent,
pubmed-meshheading:9715895-Adult,
pubmed-meshheading:9715895-Blood Banks,
pubmed-meshheading:9715895-Blood Specimen Collection,
pubmed-meshheading:9715895-Child,
pubmed-meshheading:9715895-Cryopreservation,
pubmed-meshheading:9715895-Europe,
pubmed-meshheading:9715895-Female,
pubmed-meshheading:9715895-Fetal Blood,
pubmed-meshheading:9715895-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:9715895-Hematopoietic Stem Cells,
pubmed-meshheading:9715895-Humans,
pubmed-meshheading:9715895-Male,
pubmed-meshheading:9715895-Middle Aged,
pubmed-meshheading:9715895-Registries,
pubmed-meshheading:9715895-Tissue Donors,
pubmed-meshheading:9715895-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Cord blood banking and transplant in Europe. Eurocord.
|
pubmed:affiliation |
Hôpital St Louis, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|